医学
利拉鲁肽
2型糖尿病
心脏病学
内科学
能量学
灌注
糖尿病
内分泌学
生态学
生物
作者
Amrit Chowdhary,Sharmaine Thirunavukarasu,Tobin Joseph,Nicholas Jex,Sindhoora Kotha,Marilena Giannoudi,Henry Procter,Lizette Cash,Sevval Akkaya,D Broadbent,Hui Xue,Peter Swoboda,Ladislav Valkovič,Peter Kellman,Sven Plein,Oliver J. Rider,Stefan Neubauer,John P. Greenwood,Eylem Levelt
标识
DOI:10.1016/j.jacc.2024.04.064
摘要
Type 2 diabetes (T2D) is characterized by insulin resistance (IR) and dysregulated insulin secretion. Glucagon-like peptide-1 receptor agonist liraglutide promotes insulin secretion, whereas thiazolidinedione-pioglitazone decreases IR.
科研通智能强力驱动
Strongly Powered by AbleSci AI